浙海德曼(688577.SH):海外市場可能會做更多的一些佈局
格隆匯5月4日丨有投資者向浙海德曼(688577.SH)提問:公司海外市場的未來規劃?
浙海德曼回覆:公司之前海外的訂單以普及型和東南亞國家為主。隨着這幾年公司高端機牀的發展,通過一些展會受到了國外特別是歐美國家的關注,尤其是2022年,我們整個海外市場的形勢是非常好的,最近的北京機牀展,我們也獲得了很多的訂單信息量,所以整個增長勢頭會比較好。公司目前還是以國內銷售市場為主,隨着企業的產能更加的釋放,我們可能海外市場可能會做更多的一些佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.